Nutriband Inc. has announced a 25% preferred stock dividend. Shareholders of record on July 25th, 2025, will receive one preferred share for every four shares of common stock held. This marks a new dividend issuance as the company moves towards FDA approval for its AVERSA Fentanyl product.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9488153-en) on July 02, 2025, and is solely responsible for the information contained therein.